Drug Ads: FDA Rulemaking Meets Legal Headwinds

Direct-to-consumer drug ads have long blurred the line between patient empowerment and corporate persuasion, but the FDA is now moving to rein in misleading tactics on TV and social media. However, free speech protections and post-Chevron limits on agency authority are in play.


Comment
Show comments Hide Comments


Related Articles